Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 2950503, 12 pages
http://dx.doi.org/10.1155/2016/2950503
Review Article

Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury

1School of Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia
2Clinic for Nephrology, Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia
3Department of Life Sciences, Institute for Multidisciplinary Research, University of Belgrade, Kneza Vieslava 1, 11000 Belgrade, Serbia
4Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, P.O. Box 38, 11000 Belgrade, Serbia
5Clinical Pharmacology Unit, University Children’s Hospital, 11000 Belgrade, Serbia

Received 19 February 2016; Accepted 28 April 2016

Academic Editor: Jacek Zielonka

Copyright © 2016 Aleksandra Kezic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Aleksandra Kezic, Ivan Spasojevic, Visnja Lezaic, and Milica Bajcetic, “Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2950503, 12 pages, 2016. https://doi.org/10.1155/2016/2950503.